Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Research Communications of the 32nd ECVIM‐CA Online Congress

ABSTRACT:

SUBMITTER:

PROVIDER: S-EPMC9708443 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

RESEARCH COMMUNICATIONS OF THE 30th ECVIM-CA ONLINE CONGRESS. 2-5 September 2020.

Project description: Not available

| S-EPMC7694800 | biostudies-literature

Research Communications of the 26th ECVIM‐CA Congress

Project description: Not available

| S-EPMC5259643 | biostudies-literature

Correction to: 12th European Headache Federation Congress jointly with 32nd National Congress of the Italian Society for the Study of Headaches.

Project description:After publication of this supplement [1], it was brought to our attention that e-mail errors were apparent in the following abstracts. This has now been included in this correction.

| S-EPMC6755621 | biostudies-literature

Meeting report: 32nd International Conference on Antiviral Research.

Project description:The 32nd International Conference on Antiviral Research (ICAR), sponsored by the International Society for Antiviral Research (ISAR), was held in Baltimore, Maryland, USA, on May 12-15, 2019. This report gives an overview of the conference on behalf of the Society. It provides a general review of the meeting and awardees, summarizing the presentations, and their main conclusions from the perspective of researchers active in many different areas of antiviral research and development. As in past years, ICAR promoted and showcased the most recent progress in antiviral research, and continued to foster collaborations and interactions in drug discovery and development. The 33rd ICAR will be held in Seattle, Washington, USA, March 30th-April 3rd, 2020.

| S-EPMC7105345 | biostudies-literature

12th European Headache Federation Congress jointly with 32nd National Congress of the Italian Society for the Study of Headaches : Florence, Italy. 28-30 September 2018.

Project description: Not available

| S-EPMC6888880 | biostudies-literature

Meeting report: the 2021 FSHD International Research Congress.

Project description:Facioscapulohumeral muscular dystrophy (FSHD) is the second most common genetic myopathy, characterized by slowly progressing and highly heterogeneous muscle wasting with a typical onset in the late teens/early adulthood [1]. Although the etiology of the disease for both FSHD type 1 and type 2 has been attributed to gain-of-toxic function stemming from aberrant DUX4 expression, the exact pathogenic mechanisms involved in muscle wasting have yet to be elucidated [2-4]. The 2021 FSHD International Research Congress, held virtually on June 24-25, convened over 350 researchers and clinicians to share the most recent advances in the understanding of the disease mechanism, discuss the proliferation of interventional strategies and refinement of clinical outcome measures, including results from the ReDUX4 trial, a phase 2b clinical trial of losmapimod in FSHD [NCT04003974].

| S-EPMC8762812 | biostudies-literature

Meeting report: the 2020 FSHD International Research Congress.

Project description: Not available

| S-EPMC7721607 | biostudies-literature

Pulmonary Vascular Research Institute World Congress 2017 Scientific Abstracts.

Project description: Not available

| S-EPMC5703125 | biostudies-literature

2022 Annual World Congress of the Pulmonary Vascular Research Institute

Project description: Not available

| S-EPMC9748629 | biostudies-literature

2020 Annual World Congress of the Pulmonary Vascular Research Institute.

Project description: Not available